Discover - Baylor Research Institute

Real Innovation, Right Here

Patient Impact from Bench to Bedside

Real Innovation, Right Here - Patient Impact from Bench to Bedside

Baylor Scott & White Research Institute

Established in
1984
Backed by the Baylor Scott & White storied legacy and passion for patient care.
300+
Active research investigators experienced in drug, device and vaccine studies
microscope
More than 3,000 board-certified physicians
beakers
more than
1,000
active clinical trials
approximately
250
scientists, laboratory assistants and research coordinators
microscope
serving more than
800,000
people at medical centers in central and North Texas
International collaborations enable research from both a homegrown and abroad standpoint, allowing BRI researchers to interact with, teach and learn from investigators around the world
microscope

Numbers Highlights

Our reputation for medical innovation and groundbreaking discoveries enhances Baylor Scott & White Health’s ability to attract the most skilled professionals on both the research and the clinical sides.

84 principal investigators added
1,001
active studies
163
studies completed
75 studies funded by NIH
70 studies funded by the Baylor
Health Care System Foundation
10,230 patient visits
5,255 new research patients

Our Team

BRI Board of Trustees

Ronald D. Murff

Ronald D. Murff

Director, Federal Home Loan Bank of Dallas (Chairman Elect)
Read Bio >

Kent Eastman

Kent Eastman

State President, Texas Executive Vice President, Commercial Banking, Capital One Bank
Read Bio >

Erle Nye

Erle Nye

Chairman Emeritus, TXU Corp., President, EN Consulting
Read Bio >

John B. McWhorter III

John B. McWhorter III

Chief Human Resources Officer (Interim) of Baylor Scott & White Health, Senior Vice President, Baylor Scott & White Health, President, Baylor University Medical Center at Dallas
Read Bio >

Paul B. Convery, MD

Paul B. Convery, MD


Read Bio >

Our Team

Executive Leadership

Michael A. E. Ramsay, MD, FRCA

Michael A. E. Ramsay, MD, FRCA

President of the Baylor Research Institute
Read Bio >

Jaime Walkowiak, JD

Jaime Walkowiak, JD

Chief Operating Officer and Senior Vice President of Research
Read Bio >

Renee Day, CPA

Renee Day, CPA

Chief Financial Officer and Vice President
Read Bio >

Elizabeth Cothran

Elizabeth Cothran

Vice President and Chief Regulatory Officer
Read Bio >

Our Team

Directors

M. Virginia Pascual, MD

M. Virginia Pascual, MD

Investigator
Read Bio >

Gerard Zurawski, PhD

Gerard Zurawski, PhD

Investigator, Director, Center for Biotechnology, Co-Director of Baylor Institute for Immunology Research
Read Bio >

Ajay Goel, PhD

Ajay Goel, PhD

Investigator, Director, Center for Gastrointestinal Research, Director, Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute, Baylor University Medical Center
Read Bio >

Raphael Schiffmann, MD, MHSC

Raphael Schiffmann, MD, MHSC

Director of the Institute of Metabolic Disease at Baylor Research Institute
Read Bio >

Our Investigators

View

Real Innovation

currently, more than
600 issued patents and pending
applications in the following areas:
  • Biomarkers for colorectal and other gastrointestinal cancers
  • Cell regeneration and islet cell transplantation
  • Cardiovascular disease
  • Metabolic disease treatment, diagnosis and monitoring
  • Immunological biosignatures for diagnosis, treatment and monitoring
  • Metabolomics
  • Immunotherapies for cancer, autoimmune disease, infectious disease and other immune disorders

Where Research Happens

Additionally, studies related to health care quality highlight innovations associated specifically with the delivery of care. This allows us to serve more than 800,000 people at medical centers in Dallas, Fort Worth, Garland, Grapevine, Irving, Plano, Waxahachie, Denton, Carrollton, Waco, Round Rock, Cedar Park, Brenham, College Station, Llano, Marble Falls, Taylor and Temple.

texas-new

Within Texas alone, statewide collaborations and joint research efforts are bringing more innovations to Texans than ever. Notably, the merger of Baylor Health Care System with Scott & White Healthcare connected the talents and resources of two major health care systems in North and Central Texas, resulting in a wider geographic reach and broader capabilities. In addition, the Collaborative Faculty Research Investment Program (CFRIP) is a joint initiative from Baylor University, Baylor Scott & White Health and the Baylor College of Medicine that funds selected projects across the state. Additionally, grants from the Cancer Prevention & Research Institute of Texas (CPRIT) have supported Baylor’s oncology research significantly.

In May 2015, Baylor Research Institute and Arizona’s Translational Genomics Research Institute (TGen) launched a unique collaboration related to oncological precision medicine. The significant agreement pairs BRI’s strengths in metabolomics and immune-based approaches with TGen’s forte in genomics and proteomics. As a result, the joint effort, which focuses on early detection and cancer treatment, will give patients greater access to liquid biopsies, gene sequencing, personalized vaccines and expanded clinical trials.

International collaborations extend our reach beyond Texas, allowing BRI researchers to interact with, teach and learn from investigators around the world. This global component provides a unique and exclusive opportunity for local patients to access important clinical trials taking place beyond Texas’ borders.